Effect of mycophenolic acid glucuronide on inosine monophosphate dehydrogenase activity

Therapeutic Drug Monitoring

Volumn 19, Issue 3, 1997, Pages 358-360

  Nowak, Irena ^a   Shaw, Leslie M ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Inhibition; Inosine monophosphate dehydrogenase; Kinetics; Mycophenolic acid glucuronide

Indexed keywords

DRUG METABOLITE; ENZYME INHIBITOR; INOSINATE DEHYDROGENASE; INOSINE PHOSPHATE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID BETA D GLUCURONIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; XANTHINE DERIVATIVE; XANTHOSINE PHOSPHATE;

ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INHIBITION KINETICS; PRIORITY JOURNAL;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; IMP DEHYDROGENASE; INOSINE MONOPHOSPHATE; KINETICS; MYCOPHENOLIC ACID;

EID: 0031436795     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007691-199706000-00018     Document Type: Article

References (11)

1. Eugui EM, Almquist SJ, Muller CD, Allison AC. Lymphocyte-selective cytostatic and immunosuppressive effect of mycophenolic acid in vitro: role of deoxyguanosine nucleotide depletion. Scand J Immunol 1991;33:161-73.
2. Nagai M, Natsumeda Y, Konno Y, Hoffman R, Irino S, Weber G. Selective up-regulation of type II inosine 5′-monophosphate dehydrogenase messenger RNA expression in human leukemias. Cancer Res 1991;51:3886-90.
3. Nagai M, Natsumeda Y, Weber G. Proliferation-linked regulation of type II IMP dehydrogenase gene in human and normal lymphocytes and HL-60 leukemic cells. Cancer Res 1992;52: 258-61.
4. Wu JC. Mycophenolate mofetil: molecular mechanisms of action. Perspect Drug Disc Design 1994;2:185-204.
5. Ransom JT. Mechanism of action of mycophenolate mofetil. Ther Drug Monit 1995;17:681-4.
6. Report of the Antiviral Drug Advisory Committeee, Subcommittee on Immunosuppressant Drugs. March 30, 1995.
7. Bullingham RES, Nicholls A, Hale M. Pharmacokinetics of mycophenolate mofetil (RS61443): a short review. Transpl Proc 1996;28:925-9.
8. Carr SF, Papp E, Wu JC, Natsumeda Y. Characterization of human type I and II IMP dehydrogenases. J Biol Chem 1993;268:27286-90.
9. Tsina I, Chu F, Hama K, et al. Manual and automated (robotic) high-performance liquid chromatography methods for the determination of mycophenolic acid and its glucuronide conjugate in human plasma. J Chromatogr 1996;675:119-29.
10. Langman LJ, LeGatt DF, Yatscoff RW. Pharmacologic assessment of mycophenolic acid-induced immunosuppression by measuring IMP dehydrogenase activity. Clin Chem 1995; 41:295-9.
11. Cha S. Tight-binding inhibitors. I. Kinetic behavior. Biochem Pharm 1975;24:2177-85.